Recently developed criteria for diagnosis of mild cognitive impairment due to Alzheimer disease make use of clinical and biomarker information. A new study reports that these criteria apply in both community and research settings; however, results from the community-based cohort conflict with a proposed biomarker-based model of disease progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Petersen, R. C. Clinical practice. Mild cognitive impairment. N. Engl. J. Med. 364, 2227–2234 (2011).
Cummings, J. L., Dubois, B., Molinuevo, J. L. & Scheltens, P. International work group criteria for the diagnosis of Alzheimer disease. Med. Clin. North Am. 97, 363–368 (2013).
Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 270–279 (2011).
Petersen, R. C. et al. Criteria for mild cognitive impairment due to Alzheimer's disease in the community. Ann. Neurol. http://dx.doi.org/10.1002/ana.23931.
Jack, C. R. Jr et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207–216 (2013).
Prestia, A. et al. Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology 80, 1048–1056 (2013).
Vos, S. J. et al. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI. Neurology 80, 1124–1132 (2013).
van Harten, A. C. et al. Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints. Alzheimers Dement. http://dx.doi.org/10.1016/j.jalz.2012.08.004.
Visser, P. J., Vos, S., van Rossum, I. & Scheltens, P. Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease. Alzheimers Dement. 8, 560–563 (2012).
van Rossum, I. A. et al. Injury markers predict time to dementia in subjects with MCI and amyloid pathology. Neurology 79, 1809–1816 (2012).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Scheltens, P. Mild cognitive impairment—amyloid and beyond. Nat Rev Neurol 9, 493–495 (2013). https://doi.org/10.1038/nrneurol.2013.147
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2013.147
